How dangerous food-borne pathogen evades body”s defenses

Washington, May 14 (ANI): Stanford University School of Medicine investigators have deciphered how Listeria monocytogenes, a dangerous food-borne pathogen, slips through the intestine”s defenses and causes disease.

This bacterial strain thrives in salty or cold environments where prissier pests might perish: cold cuts, smoked salmon, soft cheeses and many a refrigerator. Abundant in the environment, it seldom causes disease in humans — but when it does, it”s deadly.

Manuel Amieva, MD, PhD, assistant professor of pediatrics and of microbiology and immunology, is the senior author of a study that describes the way Listeria grabs onto molecular handles on cells in the small intestine and then switches on those cells” own uptake systems to hitch a ride inside.

The study will be published online May 13 in PLoS Pathogens. Mickey Pentecost, PhD, a recent graduate from Amieva”s laboratory, is the first author.

We think of the small intestine as a long, smooth, hollow tube through which torrents of nutrient-rich food flow. But close inspection shows that the gut”s inner surface lining, known as the intestinal epithelium, is anything but smooth. In fact, it”s much more like the Rocky Mountains than the Great Plains. The gut”s serrated character vastly increases its surface area, which in turn increases nutrient absorption.

The microscopic mountains of the intestine”s rugged surface terrain are called villi. Amieva and his colleagues have previously shown that cells at the very tips of villi are particularly vulnerable to infection by Listeria. But gaining that unauthorized access is no mean feat. The cells of the intestinal epithelium are tightly stitched together by molecules on their cell surfaces that connect them to each other.

The tight junctions formed in this way effectively seal off the intestine from the microbes that course through our digestive tracts. And luckily so: Even normally benign bugs — there are trillions of them in our gut — would cause serious problems if they could squeeze through the intestinal wall and enter the bloodstream.

Listeria and other invasive organisms manage to get around that seal, said Amieva. “You get a new intestinal epithelial lining every week,” he said. “The cells at the tips of the villi are constantly dying and being shed, at the rate of 10 billion a day. When a cell dies it is shed into the hollow space of the gut. To avoid leaving holes, the surrounding cells quickly move closer together and re-assemble tight junctions. But in the process, the normally hidden molecules that dot the sides of the cells abutting the hole — like the sides of teeth adjacent to one that just fell out — get transiently exposed.”

Listeria exploits these exposed spots by doing a sophisticated two-step.

Like many other microbes, Listeria manufactures a couple of hooks (Listeria”s are known as Internalin A and Internalin B) that grab onto specific molecules protruding from cells of the intestinal lining. Internalin A”s targeted molecule, E-cadherin, is a key player in forging the junctions between adjacent cells of the gut epithelium. The target for Internalin B is C-Met, a receptor for a growth factor (growth factors are external molecules that can drastically change a cell”s behavior).

Both E-cadherin and C-Met are typically located along the normally inaccessible sides of villus cells. This was puzzling, said Amieva. “E-cadherin and C-Met would seem to be unlikely attachment sites. Why on earth would a microbe pick such hard-to-reach sites to grab onto?” (ANI)

Novel, improved gluten-free foods for celiac disease patients developed

Washington, May 6 (ANI): A wide range of gluten free cereals has been developed for patients with celiac disease, say researchers.

Enzyme technology, bioprocessing as well as high-pressure processing technology have been successfully applied to improve the quality, safety and nutritional attributes of gluten free cereal products.

In genetically susceptible individuals, the ingestion of gluten and related proteins triggers an immunemediated enteropathy known as Coeliac Disease (CD).

Coeliac patients eating wheat or related proteins such as hordeins (barley) or secalins (rye) undergo an immunological response, localized in the small intestine, which destroys mature absorptive epithelial cells on the surface of the small intestine.

Currently, the only way that CD can be treated is the total lifelong avoidance of gluten ingestion. Therefore, CD suffers have to follow a very strict diet and avoid any products which contain wheat, rye or barley. Some authors also include oats. Avoidance of these cereals leads to a recovery from the disease and significant improvement of the intestinal mucosa and its absorptive functions. Coeliac patients are not in position to eat some of the most common foods such as bread, pizzas, biscuits or drink beer.

Due to the unique properties of gluten, it is a big challenge for food scientists to produce good quality gluten free products.

The areas covered during the new project were a detailed characterisation of gluten free cereals and the assessment of these cereals as potential ingredients for gluten free breads. The characterizations ranged from a detailed chemical characterisation to rheological evaluation of the resulting doughs, structural properties of the doughs and breads using advanced microscopic methods as well as pilotscale baking trials and sensory evaluation. Novel methods to improve the quality of gluten free cereal products were also covered; one example being the use of specially selected Lactic acid bacteria with properties such as antifungal activity, exopolysaccharide production and enzyme production. The use of specifically selected Lactic acid bacteria can significantly improve the quality and shelf-life of gluten free breads. (ANI)

Low-moderate alcohol consumption does not harm women”s bone health

Washington, April 28 (ANI): A new study has offered more evidence that low to moderate alcohol consumption does not harm bone health in women.

There is lack of information on low to moderate alcohol consumption and bone health, especially in women.

This may be particularly important because alcoholics tend to have weak bones – possibly due to low levels of vitamin D, which would hinder absorption of dietary calcium in the small intestine.

To help fill in a knowledge gap in this area, researchers at the National Cancer Institute (NCI) and the US Department of Agriculture ARS Beltsville Human Nutrition Research Center teamed up to rigorously test whether they could demonstrate any negative effects of low to moderate alcohol consumption on bone health in postmenopausal women.

This study was part of the Women”s Alcohol Study, which involved 51 postmenopausal women who did not smoke or use hormone replacement therapy.

The research team measured the effects of controlled alcohol consumption during three periods of time. In one of these experimental periods, subjects consumed an alcohol-free beverage once each day.

During the other two, they consumed either 15 or 30 g of nearly pure alcohol (Everclear) served up in orange juice.

These amounts of alcohol are equivalent to 1 or 2 glasses, respectively, of wine or a bottle of beer. Each study period lasted for 8 weeks, during which time all meals were also provided to the women- either in the USDA”s Beltsville Human Nutrition Research Center or provided as “take-out” for the weekends.

The researchers did not find any negative effects of either dose of alcohol on circulating levels of vitamin D.

Low to moderate intake also did not affect a variety of markers (single-nucleotide polymorphisms or SNPs), which influence alcohol metabolism.

These results suggest that the relationship previously documented between alcohol consumption and bone disease in alcoholics may only be seen in very heavy drinkers, or may be due to something other than the alcohol itself.

“It looks like low to moderate alcohol consumption, at least over the short term, does not harm bone health. Collectively, when all the available published epidemiologic data are considered, it looks like low to moderate alcohol may actually have a beneficial effect,” said Dr. Somdat Mahabir.

The results of the study were presented on April 27, 2010 at the Experimental Biology 2010 meeting in Anaheim. (ANI)

Study promises defence against diarrhoea

Washington, April 26 (ANI): The findings of a new American research could soon provide defence against infections caused by waterborne microscopic pathogen cryptosporidium.

Found in swimming pools, water parks, and drinking water supplies, cryptosporidium is a leading cause of diarrhoea and malnutrition and the most common source of infection in immune-weakened people such as AIDS patients.

It is also a potential bioterrorism agent.

Brandeis University biochemist Liz Hedstrom said: “All you need is a cow and a centrifuge to harvest enough oocysts to infect a small city.”

Roughly 20 percent of calves are infected by cryptosporidium oocysts, which are found in their feces.

In 1993, in the largest waterborne disease outbreak in US history, this protozoan parasite infiltrated Milwaukee”s municipal water supply, killing more than 100 people and sickening some 400,000.

Cryptosporidium invades the small intestine, where it opens fire, typically causing severe gastrointestinal distress and even death in people with weakened immune systems.

Cryptosporidium is a hardy foe whose oocysts – a spore-like phase in the parasite life cycle – remain stable outside a host for long periods and are resistant to conventional water treatment such as chlorine disinfection.

Hedstrom and her collaborators made a critical breakthrough in eroding cryptosporidium defenses when they identified IMPDH, a key enzyme involved in the biosynthesis of RNA and DNA, as a potential drug target.

Her research has shown that IMPDH inhibitors block the parasite from proliferating in vitro. Importantly, the Cryptosporidium IMPDH has very different properties from those of the human enzyme counterpart.

Next, Hedstrom and her colleagues identified compounds that blocked the action of the Cryptosporidium IMPDH, but spared human IMPDH. Leading a large-scale screen of a commercial library containing 129,000 compounds, Hedstrom discovered more than fifty compounds that specifically inhibit the parasite enzyme.

A number of these compounds display antiparasitic activity. Hedstrom is now working on improving the compounds” potency, bioavailability and metabolic stability, a first step in the drug development process.

Hedstrom said: “It”s a difficult problem, but we think that we have some very promising compounds.”

Hedstrom discussed the research in her talk, titled “Targeting a prokaryotic protein in a eukaryotic parasite,” at the American Society for Biochemistry and Molecular Biology”s annual meeting on April 25. (ANI)

Cancer Prevention Coalition Challenges “Honest Food Labels” Article

Statement from the Cancer Prevention Coalition
CHICAGO–(Business Wire)–
As reported in a March 18, New York Times editorial, “Honest Food Labels,” FDA
Commissioner, Margaret Hamburg, M.D., publicized letters to 17 food companies
accusing them of — “masking undesirable ingredients” — in their products. She
also emphasized the importance of “providing nutrition information that
consumers can rely on.” Unfortunately, she has failed to take any such action
with regard to the two major dietary staples, milk and meat.

About 20% of our milk is genetically engineered, technically known as rBGH
(recombinant Bovine Growth Hormone), which contains high levels of a natural
growth factor known as IGF-1 (Insulin-like Growth Factor one). This survives
digestion and is readily absorbed from the small intestine into the blood.
Increased levels of IGF-1 have been shown to increase risks of breast cancer in
19 scientific publications, risks of colon cancer in 10 publications, and
prostate cancer in 7 publications. Of further concern, increased IGF-1 levels
block natural defense mechanisms against early microscopic cancers, known as
apoptosis.

Based on these concerns, on June 3, 1999, the United Nations Food Safety Agency,
representing 101 nations worldwide, ruled unanimously not to endorse or set
safety standards for rBGH milk. Effectively, this has resulted in an
international ban on U.S. milk.

Also based on these concerns, the Cancer Prevention Coalition, endorsed by five
leading national experts, petitioned the FDA in May 2007 to label rBGH milk with
an explicit cancer warnings. In the absence of any response, we resubmitted this
petition in January 2010 to Dr. Hamburg, and are waiting for a response.

U.S. cattle are implanted with natural or synthetic sex hormones prior to
entering feed lots 100 days prior to slaughter in order to increase their meat
yield. Not surprisingly, our meat is contaminated with high levels of sex
hormones. Based on these concerns, and as warned by the Cancer Prevention
Coalition and five leading national experts, our meat poses increased risks of
hormonal cancers, which have escalated since 1975: breast by 23%, prostate by
60%, and testis by 60%. Not surprisingly, U.S. meat is banned worldwide.

Furthermore, as clearly evidenced in a series of General Accounting Office
investigations and Congressional hearings, the FDA, besides the U.S. Department
of Agriculture (USDA), have failed to take any regulatory action to protect the
public from the dangers of hormonal meat. A 1986 report, “Human Food Safety and
Regulation of Animal Drugs,” unanimously approved by the House Committee on
Government Operations, concluded that the “FDA has consistently disregarded its
responsibility — has repeatedly put what it perceives are interests of
veterinarians and the livestock industry ahead of its legal obligation to
protect consumers — jeopardizing the health and safety of consumers meat, milk,
and poultry.”

In response to questions on the dangers of hormonal meat raised by the European
Commission in February 1996, the USDA responded with unsubstantiated claims that
less than 0.25% of animals tested annually proved positive for “residue
violations.” In fact, meat has not been and is still not monitored for sex
hormone levels by the USDA or FDA.

Together with other leading scientific experts, on January 29, 2010, the Cancer
Prevention Coalition submitted a Citizens Petition to the FDA on the “Imminent
health Hazard” from hormonal meat, supported by 59 scientific references. We are
waiting for a response.

Not surprisingly, U.S. milk and meat are virtually banned worldwide.

Samuel S. Epstein, M.D.
Professor emeritus Environmental & Occupational Medicine
University of Illinois Chicago School of Public Health
Chairman, Cancer Prevention Coalition
email: epstein@uic.edu
www.preventcancer.com
To subscribe: http://ens-news.net/lists/?p=subscribe&id=9

Copyright Business Wire 2010

Bile sends mixed signals to gut bacteria for boosting survival

Washington, Apr 1 (ANI): In the small intestine, bile secretions send signals to disease causing gut bacteria enabling them to change their behaviour to extend their chances of survival, according to a Montana State University scientist.

The findings by Steve Hamner and colleagues could allow us to better protect food from contamination by these harmful bacteria, as well as understand how they manage to cause disease.

Bile is secreted into the small intestine and exerts an antibacterial effect by disrupting bacterial membranes and damaging bacterial DNA, said the study.

While bile is a human defense mechanism, the researchers found that some bacteria such as Escherichia coli O157:H7 — an important food-borne pathogen known as E. coli — have evolved to use the signal to their advantage.

These bacteria use the presence of bile as a signal to tell them that they are in the intestine, which allows them to adapt and prepare to cause disease.

They found that bile causes the bacteria to switch on genes needed to increase iron uptake.

“This is useful in iron-scarce environments — such as the small intestine — as iron is an essential nutrient for bacterial growth. By increasing its chances of absorbing iron, the bacterium is maximizing its survival chances,” explained Hamner.

E. coli O157:H7 primarily infects the large intestine, and this study provides one explanation why this is the case.

“We found that bile causes the bacteria to turn off genes that promote tight attachment to host cells. Bile may effectively prevent these bacteria from latching onto the epithelial cells that line the small intestine,” suggested Hamner.

As bacteria move further down the digestive tract towards the large intestine, the concentration of bile decreases.

“The reduced concentration of bile in the large intestine may then be a signal for the bacteria to switch on their ability to attach to epithelial cells and to prepare to secrete toxins,” said Hamner.

Studying the conditions that make these bacteria more likely to attach themselves to cells could help reduce outbreaks of food poisoning.

“By learning how the bacteria attach to food surfaces such as spinach leaves or to host tissues such as the lining of the intestine, we hope to better be able to protect food sources from contamination by these bacteria. Studying how these bacteria interact with hosts such as humans or cows could teach us how to interfere with the way that these bacteria cause disease,” said Hamner.

The study was presented at the Society for General Microbiology during its spring meeting in Edinburgh, Scotland. (ANI)

Scorpion venom may help understand cause, treatment of pancreatitis

Washington, Mar 30 (ANI): Researchers at North Carolina State University and East Carolina University have gained insight into scorpion venom”s effects on the ability of certain cells to release critical components – a finding that may prove useful in understanding diseases like pancreatitis or in targeted drug delivery.

A common result of scorpion stings, pancreatitis is an inflammation of the pancreas.

ECU microbiologist Dr. Paul Fletcher believed that scorpion venom might be used as a way to discover how pancreatitis occurs – to see which cellular processes are affected at the onset of the disease.

Fletcher pinpointed a protein production system found in the pancreas that seemed to be targeted by the venom of the Brazilian scorpion Tityus serrulatus and then contacted NC State physicist Dr. Keith Weninger, who had studied that particular protein system.

“This particular protein system has special emphasis at two places in the body – the pancreas and the nervous system,” Weninger says. “In the pancreas, it is involved in the release of proteins through the membrane of a cell.”

The pancreas specializes in releasing two kinds of proteins using separate cells: digestive enzymes that go into the small intestine and insulin and its relatives that go into the bloodstream, yet this same release mechanism is important in all of our cells for many processes.

Cells move components in and out through a process called vesicle fusion. The vesicle is a tiny, bubble-like chamber inside the cell that contains the substance to be moved, stored and released – in this case, proteins like enzymes or hormones. The vesicle is moved through the cell and attaches to the exterior membrane, where the vesicle acts like an airlock in a spaceship, allowing the cell membrane to open and release the proteins without disturbing the rest of the cell”s contents. The proteins that aid in this process are known as Vesicle Associated Membrane Proteins, or VAMPs.

Weninger provided Fletcher with two different VAMP proteins found in the pancreas, VAMP2 and VAMP8. They were engineered to remove the membrane attachments so they could be more easily used for experiments outside cells and tissues. Fletcher”s team demonstrated that the scorpion venom attacked the VAMP proteins, cutting them in one place and eliminating the vesicle”s ability to transport its protein cargo out of the cell.

The results were published in the March 5 issue of the Journal of Biological Chemistry.

“We found that a particular enzyme in the scorpion”s venom removes a peptide, or small protein, that allows the vesicle to fuse with the cell membrane,” Fletcher says. “If you remove a pancreatic cell”s ability to absorb or release components, you end up with pancreatitis.”

“Viruses often exploit the same mechanism of vesicle fusion, but in reverse, in order to invade cells and replicate,” Weninger adds. “This work furthers our understanding of a basic cellular process and may lead to treatments for viruses and advances in treatments like chemotherapy, by allowing targeted drug delivery only to cancer cells.” (ANI)

HIV-1 destroys immune response in the gut within days of infection

Washington, July 7 (ANI): Researchers have found that HIV-1 virus moves rapidly in the body, and damages the B-cell antibody-producing system in the gut, within days of infection.

The study by Centre for HIV/AIDS Vaccine Immunology is the first to examine what happens to B cells in the gut in the earliest stage of HIV-1 infection.

“These new data show that damage to the antibody arm of the immune system begins quickly, within days. We know that by 80 days, half of the generative microenvironments for antibodies within the immune system in the gut are destroyed,” said Dr. Barton Haynes, senior author of the study.

The findings could solve one of the big mysteries in HIV-why the B cell, or antibody response, is so slow to arise in the first place and turns out to be so weak after it does, that it is unable to offer any kind of meaningful defence.

B cells that make antibodies against invading microbes are born in the bone marrow, but migrate out and mature in different locations throughout the body.

Some wind up in the intestine and settle in stretches of lymph node-like follicles called Payer’s patches, which are found at the bottom of the small intestine, where they wait to rise up against incoming bacteria, viruses, or other pathogens.

“Unfortunately, we found they are no match for HIV-1,” said Anthony Moody, a lead author of the study.

For the study, the researchers examined B cells in blood as early as 17 days after viral transmission, and in lymph tissue in the gut beginning at 47 days after transmission in 40 people infected with HIV-1.

They compared their findings with similar tissue from healthy controls, and found that even at the early stage, HIV-1 had already ravaged the gut’s B cell arm of the immune system.

The vast majority of the follicles in the Payer’s patches had been damaged.

“HIV-1 turns on the immune system, but turns it on in the wrong way. We found that it was churning out all sorts of B cells. Some appeared to be reactive against HIV-1, but others appeared reactive to things like influenza as well as self molecules,” said Moody.

Besides, it was found that by as early as 17 days after transmission, HIV-1 decreased the numbers of naive B cells – cells that may have had the potential to mature into potent infection-fighters.

The researchers are hoping that the findings may lead to a successful AIDS vaccine.

The study has been published in the open access journal PLoS Medicine. (ANI)

Gastrin levels vital in bacterial-induced stomach cancer

Washington, June 24 (ANI): Gastrin levels have a very important role to play in the development of Helicobacter-induced stomach cancer, according to a study.

Over 50 percent of the world’s population is infected with Helicobacter pylori, which causes chronic inflammation of the stomach lining, and is strongly linked to the development of gastric ulcers and stomach cancer.

Stomach cancer is the second leading cause of cancer-related deaths worldwide.

Helicobacter infection results in increased expression of gastrin, a hormone that stimulates secretion of gastric acid.

However, the role of gastrin in cancer development still remains unclear.

While high levels of gastrin lead to the development of stomach cancer, but absence of gastrin has been shown to increase the numbers of tumours in the gastric antrum- the lower section of the stomach that empties into the small intestine.

Thus, for explaining this apparent disparity, a group led by Dr. Timothy Wang at the Columbia University Medical Center in New York, NY examined the contribution of Helicobacter infection to gastric cancer in animal models with either high expression of gastrin or no gastrin at all.

It was found that Helicobacter infection in mice with high levels of gastrin resulted in cancer of the gastric corpus (main body of the stomach).

On the other hand, infection in gastrin-deficient mice led to cancer in a different part of the stomach- the gastric antrum.

Thus, the researchers concluded that gastrin plays a key role in the development of Helicobacter-induced stomach cancer, but may have distinct effects on carcinogenesis in different parts of the stomach.

The related report by Takaishi et al, ‘Gastrin is an essential cofactor for Helicobacter-associated gastric corpus carcinogenesis in C57BL/6 mice’, is appearing in the upcoming issue of The American Journal of Pathology. (ANI)

Fatty foods ‘offer long-term memory formation’

Washington, Apr 28 (ANI): Can’t stop thinking about that rich, delicious hot chocolate fudge you had last night? Well, if it’s so, then you shouldn’t feel like a glutton, because the feeling is natural.

A new study by UC Irvine researchers has found that eating something fattening and delicious creates long-term memories of the experience that may contribute to bad eating habits.

The study has been published in the early online edition of the Proceedings of the National Academy of Sciences.

Daniele Piomelli, the Louise Turner Arnold Chair in Neurosciences, teamed with UCI’s James McGaugh, one of the world’s leading learning and memory researchers, to examine how dietary fats facilitate memory retention.

Piomelli’s previous studies identified how oleic acids from fats are transformed into a compound called oleoylethanolamide (OEA) in the upper region of the small intestine. OEA sends hunger-curbing messages to the brain to increase feelings of fullness. In elevated levels, OEA can reduce appetite, produce weight loss and lower blood cholesterol and triglyceride levels.

Piomelli and McGaugh discovered that OEA also causes memory consolidation, the process by which superficial, short-term memories are transformed into meaningful, long-term ones. It does this, Piomelli said, by activating memory-enhancing signals in the amygdala, part of the brain involved in the consolidation of memories of emotional events.

The researchers found that administering OEA to rodents improved memory retention in two different tests. When cell receptors activated by OEA were blocked, memory retention effects decreased.

“OEA is part of the molecular glue that makes memories stick,” Piomelli said.

“By helping mammals remember where and when they have eaten a fatty meal, OEA’s memory-enhancing activity seems to have been an important evolutionary tool for early humans and other mammals,” the expert added.

Dietary fats are important for overall health, helping with the absorption of vitamins and the protection of vital organs. While the human diet is now rich in fats, this was not the case for early humans. In fact, fat-rich foods in nature are quite rare.

“Remembering the location and context of a fatty meal was probably an important survival mechanism for early humans. It makes sense that mammals have this capability,” Piomelli said.

He noted that such memory enhancement may not be so beneficial. While OEA contributes to feelings of fullness after a meal, it could also engender long-term cravings for fatty foods that, when eaten in excess, can cause obesity. (ANI)

Soon, gluten-free French bread for celiac disease patients

Washington, Apr 5 (ANI): Celiac disease patients, who are asked to stay away from gluten, can supplement the protein in their diet by opting for a new gluten-free bread, which resembles French bread in terms of texture and colour, according to a new study.

Celiac disease is a digestive disease that damages the small intestine and interferes with absorption of nutrients from food.

Over two million people who have celiac disease cannot tolerate gluten, a protein in wheat, rye, and barley.

And as bread is prepared mainly from wheat flour containing proteins implicated as the cause of the disease, celiac patients have been forbidden from eating bread in many countries.

The new gluten-free bread includes guar gum, buckwheat flour, whole egg powder, and whey proteins.

Breads with guar gum had colour characteristics similar to French bread.

Bread prepared with buckwheat flour had improved quality and softer texture similar to regular French bread and contained dietary fibre.

“Buckwheat flour in the actual base of ingredients was found to have interesting improving effects on the quality attributes of the bread. Sensory analysis is now underway to evaluate the acceptance of this formulation by a panel of consumers,” said lead researcher Marie de Lamballerie.

The study is published in the Journal of Food Science, published by the Institute of Food Technologists (IFT). (ANI)

How gut bacteria prevents cancer, inflammatory bowel disease in humans

Washington, Feb 6 (ANI): In a new study, researchers have found that bacteria present in the gut can release substances that may protect the body against colon cancer and inflammatory bowel disease.

Scientists at the University of Aberdeen Rowett Institute of Nutrition and Health and from the MTT Agrifood Research Institute in Finland showed that bacteria in the human gut convert linoleic acid, a naturally-occurring fat in the diet, into a form called conjugated linoleic acid (CLA) which is absorbed by the gut wall.

Dr John Wallace of the Rowett Research Institute said that there exist different types of CLA, out of which only a few have beneficial effects, and that “good” form of CLA is present in dairy foods such as milk and cheese.”

“But eating lots of dairy foods won’t necessarily help our gut health as most of the fats are digested in the small intestine before they get to the large intestine, where most of our gut bacteria are found,” he said.

The findings indicated that gut bacteria produce several different forms of CLA, most of which are of the “good” kind.

Bit Wallace stressed that more extensive studies are needed, as one subject produced small amounts of a CLA whose effects are much less clear.

Thus, the researchers deduced that if small quantities of dietary linoleic acid could be delivered to the large intestine, the effects on gut health would be generally beneficial in most people.

“The results are of special interest for individuals using anti-obesity treatments that prevent the small intestine from absorbing fats. This means that those fats – including linoleic acid – will pass into the large intestine and the gut bacteria will produce CLA. It has to be the correct CLA, so it is important to understand how individuals produce different CLA. This must depend on which types of bacteria are present,” said Wallace.

The study has been published in the journal Microbiology. (ANI)

Gastric ‘condoms’ could save dangerously obese from surgery

London, Feb 3 (ANI): A removable device that lines the gut and stops body from sucking in calories may soon offer hope for people who are dangerously obese.

Inserted into the gut through the mouth, the EndoBarrier, developed by GI Dynamics of Lexington, Massachusetts, is an impermeable sleeve that lines the first 60 centimetres of the small intestine, reports New Scientist.

But unlike a gastric band, the sleeve can be inserted in less than half an hour – without the need for surgery.

According to animal experiments and preliminary human trials, it reduces weight and rapidly brings type II diabetes under control.

Using an endoscope, the device – enclosed in a capsule – is inserted via the mouth. Once in place below the base of the stomach, the capsule releases a small ball that with the help of a catheter pulls a flexible sleeve made of the slippery polymer PTFE through the intestine.

The ball is chucked out and the sleeve is fixed in place by releasing a spiked attachment made from the shape-memory metal alloy nitinol.

Revolutionary EndoBarrier can be removed in less than 10 minutes by tugging on a drawstring to collapse the attachment device and pull out the spikes. The EndoBarrier is then pulled back out though the mouth.

“We aren’t doing anything to the stomach, so the patient can still eat normally,” says Stuart Randle, president of GI Dynamics, who adds that some patients given gastric bands find ways to fulfil their cravings for more calories.

“They can do a lot of creative things – basically putting food into blenders,” he says.

The total cost of the EndoBarrier, including installation and removal, will be around 7500dollars. This compares to 15,000 dollars or more for inserting a gastric band, or at least 20,000 dollars for a gastric bypass, says Randle. (ANI)